Skip to main content
. 2024 Mar 10;14(1):e12351. doi: 10.1002/pul2.12351

Figure 4.

Figure 4

The 6‐month event‐free survival and 2‐year survival of patients undergoing oral triple combination therapy. (a) Six‐month event‐free survival in the entire corhot; (b) 2‐year survival rates in the entire corhot; (c) Comparison of the 6‐month event‐free survival in different risk groups; (d) Comparison of 2‐year survival rates in different risk groups.